Over-Expression of GUSB Leads to Primary Resistance of Anti-PD1 Therapy in Hepatocellular Carcinoma.
Kong X, Zheng Z, Song G, Zhang Z, Liu H, Kang J, Sun G, Sun G, Huang T, Li X, Rong D, Wang K, Tang W, Xia Y.
Kong X, et al. Among authors: zheng z.
Front Immunol. 2022 Jun 22;13:876048. doi: 10.3389/fimmu.2022.876048. eCollection 2022.
Front Immunol. 2022.
PMID: 35812439
Free PMC article.